89 related articles for article (PubMed ID: 1865331)
1. Human pharmacokinetics of betaxolol enantiomers.
Stagni G; Davis PJ; Ludden TM
J Pharm Sci; 1991 Apr; 80(4):321-4. PubMed ID: 1865331
[TBL] [Abstract][Full Text] [Related]
2. Absolute bioavailability and dose proportionality of betaxolol in normal healthy subjects.
Ludden TM; Boyle DA; Gieseker D; Kennedy GT; Crawford MH; Ludden LK; Clementi WA
J Pharm Sci; 1988 Sep; 77(9):779-83. PubMed ID: 2906367
[TBL] [Abstract][Full Text] [Related]
3. Determination of betaxolol enantiomers by high-performance liquid chromatography. Application to pharmacokinetic studies.
Darmon A; Thenot JP
J Chromatogr; 1986 Jan; 374(2):321-8. PubMed ID: 3958090
[TBL] [Abstract][Full Text] [Related]
4. Betaxolol-induced deterioration of asthma and a pharmacodynamic analysis based on beta-receptor occupancy.
Miki A; Tanaka Y; Ohtani H; Sawada Y
Int J Clin Pharmacol Ther; 2003 Aug; 41(8):358-64. PubMed ID: 12940593
[TBL] [Abstract][Full Text] [Related]
5. Determination of betaxolol and its metabolites in blood and urine by high-performance liquid chromatography with fluorimetric detection.
Wong YW; Ludden TM
J Chromatogr; 1990 Dec; 534():161-72. PubMed ID: 2094703
[TBL] [Abstract][Full Text] [Related]
6. Plasma concentration of topically applied betaxolol in elderly glaucoma patients.
Vainio-Jylhä E; Vuori ML; Pyykkö K; Huupponen R
J Ocul Pharmacol Ther; 2001 Jun; 17(3):207-13. PubMed ID: 11436941
[TBL] [Abstract][Full Text] [Related]
7. Betaxolol: a new long-acting beta 1-selective adrenergic blocker.
Frishman WH; Tepper D; Lazar EJ; Behrman D
J Clin Pharmacol; 1990 Aug; 30(8):686-92. PubMed ID: 2205635
[TBL] [Abstract][Full Text] [Related]
8. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers.
Fornasini G; Monti N; Brogin G; Gallina M; Eandi M; Persiani S; Bani M; Della Pepa C; Zara G; Strolin Benedetti M
Chirality; 1997; 9(3):297-302. PubMed ID: 9176996
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of ibutilide and its enantiomers in dogs.
Hsu CY; Walters RR
Chirality; 1996; 8(1):18-23. PubMed ID: 8845277
[TBL] [Abstract][Full Text] [Related]
10. Enantioselective pharmacokinetics of the enantiomers of clevidipine following intravenous infusion of the racemate in essential hypertensive patients.
Ericsson H; Schwieler J; Lindmark BO; Löfdahl P; Thulin T; Regårdh CG
Chirality; 2001; 13(3):130-4. PubMed ID: 11270321
[TBL] [Abstract][Full Text] [Related]
11. [Electrophysiologic effects of betaxolol on conduction properties of the antegrade and retrograde pathway in patients with typical atrioventricular node reentry tachycardia following intravenous and oral administration].
Kühlkamp V; Ickrath O; Haasis R; Seipel L
Z Kardiol; 1988 Aug; 77(8):527-33. PubMed ID: 3176596
[TBL] [Abstract][Full Text] [Related]
12. Betaxolol kinetics in hypertensive children with normal and abnormal renal function.
Palminteri R; Assael BM; Bianchetti G; Gomeni R; Claris-Appiani A; Edefonti A; Morselli PL
Clin Pharmacol Ther; 1984 Feb; 35(2):141-7. PubMed ID: 6692644
[TBL] [Abstract][Full Text] [Related]
13. Concentrations of betaxolol in ocular tissues of patients with glaucoma and normal monkeys after 1 month of topical ocular administration.
Holló G; Whitson JT; Faulkner R; McCue B; Curtis M; Wieland H; Chastain J; Sanders M; DeSantis L; Przydryga J; Dahlin DC
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):235-40. PubMed ID: 16384968
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of thiopental and pentobarbital enantiomers after intravenous administration of racemic thiopental.
Nguyen KT; Stephens DP; McLeish MJ; Crankshaw DP; Morgan DJ
Anesth Analg; 1996 Sep; 83(3):552-8. PubMed ID: 8780280
[TBL] [Abstract][Full Text] [Related]
15. Observation on the efficacy and pharmacokinetics of betaxolol (SL 75212), a cardioselective beta-adrenoceptor blocking drug.
Balnave K; Neill JD; Russell CJ; Harron DW; Leahey WJ; Wilson R; Shanks RG
Br J Clin Pharmacol; 1981 Feb; 11(2):171-80. PubMed ID: 6111331
[TBL] [Abstract][Full Text] [Related]
16. Enantioselectivity in the steady-state pharmacokinetics of metoprolol in hypertensive patients.
Cerqueira PM; Cesarino EJ; Mateus FH; Mere Y; Santos SR; Lanchote VL
Chirality; 1999; 11(7):591-7. PubMed ID: 10423287
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective pharmacokinetic analysis of tramadol and its main phase I metabolites in healthy subjects after intravenous and oral administration of racemic tramadol.
García Quetglas E; Azanza JR; Cardenas E; Sádaba B; Campanero MA
Biopharm Drug Dispos; 2007 Jan; 28(1):19-33. PubMed ID: 17061296
[TBL] [Abstract][Full Text] [Related]
18. Enantioselective disposition of salbutamol in man following oral and intravenous administration.
Boulton DW; Fawcett JP
Br J Clin Pharmacol; 1996 Jan; 41(1):35-40. PubMed ID: 8824691
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of the enantiomers of mepivacaine after intravenous administration of the racemate in volunteers.
Burm AG; Cohen IM; van Kleef JW; Vletter AA; Olieman W; Groen K
Anesth Analg; 1997 Jan; 84(1):85-9. PubMed ID: 8989005
[TBL] [Abstract][Full Text] [Related]
20. Steady-state fluctuation and variability of betaxolol and atenolol plasma levels.
Kunka RL; Wong YY; Andersen RL; Haack DG
Ther Drug Monit; 1989 Sep; 11(5):523-7. PubMed ID: 2573178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
